Skip to main content

Dr. Stuart Weinerman, MD

Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)

  • Medicare participating

At a glance

Years since graduation
42
In the NPI registry since
2007
Medicare patients seen, 2024
1,771

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1984Medical school: Albert Einstein College of Medicine of Yeshiva University
  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Endocrinology, Diabetes & Metabolism Physician primary
    NY license 166011

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Endocrinology & Diabetes per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,771
Services billed
165,008
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, denosumab, 1 mg88,260859
Injection, romosozumab-aqqg, 1 mg45,15045
Injection of drug or substance under skin or into muscle1,719899
Established patient office or other outpatient visit, 30-39 minutes1,219994
Dxa bone density measurement of hip, pelvis, spine1,004990
Established patient office or other outpatient visit, 20-29 minutes441407
New patient office or other outpatient visit, 45-59 minutes148148
Hemoglobin a1c level5543
Established patient office or other outpatient visit, 40-54 minutes3532
New patient office or other outpatient visit, 60-74 minutes2626

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $11,081 in research payments for these studies, mostly to the institutions running them.

  • A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of crinecerfont (NBI-74788) in adult subjects with classic congenital adrenal hyperplasia, followed by open-label treatment
    Neurocrine Biosciences, Inc.
  • Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
    Neurocrine Biosciences, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Endocrinology & Diabetes clinicians in New Hyde Park

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 16, 2013), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1376698159. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.